PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors.

The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...

A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

Editor’s Note: PanCAN volunteers devote their time, energy and passion year-round to improving the lives of everyone impacted by pancreatic cancer. To celebrate Volunteer Appreciation Week 2025 (April ...

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic neuroendocrine tumors, also called PNET or PanNET.

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the devastating impact the cuts to federal research funding will have on ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Makes: 1 16 oz smoothie By: Tuesday Hoelscher, RDN Ingredients: 1/2 c Boost High Protein 1/2 c full fat Greek yogurt 2 tbsp chia seeds 1/2 c spinach 1/2 c mango 1 c blueberries 1/2 c orange juice ...

As of the end of January 2025, more than 8,800 participants who meet the eligibility criteria have been enrolled in PanCAN’s Early Detection Initiative, allowing the conclusion of the active ...